SEC Filing Summary: MB Software Corporation (10-K)
Business Context and Reporting Period
Company: MB Software Corporation (trading as Sanara Medtech Inc. in metadata, but filing as MB Software Corporation).
Reporting Period: Fiscal year ended December 31, 2007.
Business Model: The Company operates through its wholly-owned subsidiary, Wound Care Innovations, LLC. It holds an exclusive worldwide license to market "CellerateRx," a collagen-based advanced wound care product. The Company does not manufacture products; manufacturing is outsourced to Applied Nutritionals, and warehousing/shipping is outsourced to Diamond Contract Manufacturing.
Market: Products are FDA-cleared Class I medical devices for pressure ulcers, diabetic ulcers, and burns, with Medicare Part B reimbursement approval.
Key Financial Metrics
| Metric | 2007 | 2006 |
|---|---|---|
| Revenues | $630,505 | $189,755 |
| Cost of Revenues | $223,184 | $193,057 |
| Gross Profit | $407,321 | ($3,302) Loss |
| Gross Margin % | 64.6% | (1.7%) |
| SG&A Expenses | $813,058 | $484,583 |
| Net Loss | ($542,756) | ($623,559) |
| Cash Position (End of Period) | $781 | $236,301 |
| Total Current Liabilities | $2,219,510 | N/A |
| Stockholders' Deficiency | ($1,813,780) | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 233% year-over-year, driven by expanded product evaluations and sales to healthcare providers.
- Margin Improvement: The Company moved from a gross loss in 2006 to a gross profit of $407,321 in 2007, achieving a 64.6% gross margin.
- Expense Increase: Selling, General, and Administrative (SG&A) expenses rose 68% to $813,058 due to expanded marketing efforts and public company reporting costs.
- Liquidity Deterioration: Cash on hand plummeted from $236,301 in 2006 to $781 in 2007. Net cash used in operating activities was $380,898.
- Debt Structure: Short-term borrowings increased significantly. As of December 31, 2007, the Company held $1,498,074 in notes payable to related parties and $10,000 to non-related parties.
Outlook, Risks, and Contingencies
Going Concern Warning: The independent auditors have issued a "going concern" opinion. The Company has a significant accumulated deficit ($12.9M) and current liabilities exceeding current assets. Management states that without additional financing, the Company may be forced to curtail or cease activities.
Capital Requirements: The Company requires immediate capital to fund operations, inventory, and marketing. Plans include private placements, issuing stock for services, and loans from officers/shareholders.
Material Agreements & Obligations:
- License Agreement: Effective Nov 28, 2007, the Company entered an exclusive license with Applied Nutritionals. Obligations include a $100,000 advance royalty (due Jan 2008), 15% royalty on first-year sales, a $400,000 advance royalty (due Jan 2009), and a minimum annual royalty of $375,000 thereafter.
- Payroll Tax Delinquency: The Company is delinquent on federal payroll taxes. As of Dec 31, 2007, unpaid taxes totaled approximately $203,484, with penalties and interest of ~$123,000.
- Supplier Concentration: The Company relies on a single vendor (Applied Nutritionals) for all product manufacturing.
Subsequent Events (Post-Dec 31, 2007):
- Issued Series A Convertible Preferred Stock to Keystone Equity Partners in exchange for the cancellation of ~$1.5M in debt.
- Received $50,000 cash and issued a $700,000 convertible note in January 2008.
Investor Verification Checklist
- Cash Runway: Verify the status of the $781 cash balance and the success of the January 2008 financing ($750k total) in sustaining operations.
- Debt Cancellation: Confirm the legal finalization of the $1.5M debt-to-equity swap with Keystone Equity Partners.
- Royalty Obligations: Assess the ability to meet the $100,000 advance royalty payment due Jan 3, 2008, and the 15% sales royalty.
- IRS Liability: Determine if a payment plan has been established for the ~$326k in delinquent payroll taxes and penalties.
- Revenue Concentration: Review the dependency on the top 5 customers who accounted for the majority of 2007 revenue.